Apart from activating the expression of its immune response target genes, aberrantly activated NF-κB signalling in cancer cells contribute to cancer progression by acting as a transcriptional activator of various other pro-tumorigenic genes involved in cell proliferation, inhibition of apoptosis, invasion, metastasis and angiogenesis. The gene discussed is NFKB1; the disease is cancer.